Open access
9,849
Views
19
CrossRef citations to date
0
Altmetric
Review
Anti-CD20 treatment for B-cell malignancies: current status and future directions
Christian Kleina Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-7594-7280View further author information
Candice Jamoisb Clinical Pharmacology, Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
& Tina Nielsenc Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
Pages 161-181
|
Received 04 May 2020, Accepted 08 Sep 2020, Published online: 09 Nov 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.